ACEM

This brand name is authorized in Nigeria.

Active ingredients

The drug ACEM contains one active pharmaceutical ingredient (API):

1
UNII H1250JIK0A - CLARITHROMYCIN
 

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.

 
Read more about Clarithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-8551 Tablet Acem-500 Tablets TAB 500 mg 1 x 10's (in blister) Tablet 03/08/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-8551

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.